# Tafluprost Preservative Free Switch Study

> **NCT04654611** · PHASE4 · COMPLETED · sponsor: **Tun Hussein Onn National Eye Hospital** · enrollment: 28 (actual)

## Conditions studied

- Glaucoma
- Primary Open Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** preservative free tafluprost 0.0015%

## Key facts

- **NCT ID:** NCT04654611
- **Lead sponsor:** Tun Hussein Onn National Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-01
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2020-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04654611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04654611, "Tafluprost Preservative Free Switch Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04654611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*